An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
BACKGROUND: Bosentan has been shown to be a safe and efficacious treatment for idiopathic pulmonary arterial hypertension (PAH) and PAH associated with connective tissue disease. However, there are limited studies examining the benefits of bosentan in PAH associated with congenital heart disease (CH...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2006/746176 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560983311122432 |
|---|---|
| author | Reda Ibrahim John T Granton Sanjay Mehta |
| author_facet | Reda Ibrahim John T Granton Sanjay Mehta |
| author_sort | Reda Ibrahim |
| collection | DOAJ |
| description | BACKGROUND: Bosentan has been shown to be a safe and efficacious treatment for idiopathic pulmonary arterial hypertension (PAH) and PAH associated with connective tissue disease. However, there are limited studies examining the benefits of bosentan in PAH associated with congenital heart disease (CHD). |
| format | Article |
| id | doaj-art-f5c51c1b683c4dc9a97b207d8be44b49 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2006-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-f5c51c1b683c4dc9a97b207d8be44b492025-02-03T01:26:23ZengWileyCanadian Respiratory Journal1198-22412006-01-0113841542010.1155/2006/746176An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart DiseaseReda Ibrahim0John T Granton1Sanjay Mehta2Montreal Heart Institute, University of Montreal, Montreal, Quebec, CanadaToronto General Hospital, University of Toronto, Toronto, CanadaThe Centre for Critical Illness Research, Lawson Health Research Institute, London Health Sciences Centre, University of Western Ontario, London, Ontario, CanadaBACKGROUND: Bosentan has been shown to be a safe and efficacious treatment for idiopathic pulmonary arterial hypertension (PAH) and PAH associated with connective tissue disease. However, there are limited studies examining the benefits of bosentan in PAH associated with congenital heart disease (CHD).http://dx.doi.org/10.1155/2006/746176 |
| spellingShingle | Reda Ibrahim John T Granton Sanjay Mehta An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease Canadian Respiratory Journal |
| title | An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease |
| title_full | An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease |
| title_fullStr | An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease |
| title_full_unstemmed | An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease |
| title_short | An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease |
| title_sort | open label multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease |
| url | http://dx.doi.org/10.1155/2006/746176 |
| work_keys_str_mv | AT redaibrahim anopenlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease AT johntgranton anopenlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease AT sanjaymehta anopenlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease AT redaibrahim openlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease AT johntgranton openlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease AT sanjaymehta openlabelmulticentrepilotstudyofbosentaninpulmonaryarterialhypertensionrelatedtocongenitalheartdisease |